TenNor Therapeutics Releases Proxy Details for 29 June 2026 Annual Shareholders’ Meeting

Bulletin Express06-08

TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.

Shareholders will vote on six ordinary resolutions:

1. 2025 board of directors’ work report 2. 2025 performance report of independent non-executive directors 3. 2025 annual financial report 4. 2025 profit distribution plan 5. Remuneration plan for the current board session’s directors 6. Appointment of the external auditor for the 2026 fiscal year

H-shareholders wishing to appoint a proxy must submit the completed form—with any required notarised authorisations—to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, no later than 2:00 p.m. on 28 June 2026. Joint shareholders may vote through the first-named holder on the register, and any alterations to the proxy form must be initialled by the signatory.

The company emphasised that proxies may vote at their discretion on any resolution lacking specific shareholder instructions and on any other properly introduced business at the meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149845710?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-08 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149845710","market":"hk","top_or_hot":-1,"title":"TenNor Therapeutics Releases Proxy Details for 29 June 2026 Annual Shareholders’ Meeting","media":"Bulletin Express","content":"<p>TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.</p>\n<p>Shareholders will vote on six ordinary resolutions:</p>\n<p>1. 2025 board of directors’ work report  \n2. 2025 performance report of independent non-executive directors  \n3. 2025 annual financial report  \n4. 2025 profit distribution plan  \n5. Remuneration plan for the current board session’s directors  \n6. Appointment of the external auditor for the 2026 fiscal year</p>\n<p>H-shareholders wishing to appoint a proxy must submit the completed form—with any required notarised authorisations—to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, no later than 2:00 p.m. on 28 June 2026. Joint shareholders may vote through the first-named holder on the register, and any alterations to the proxy form must be initialled by the signatory.</p>\n<p>The company emphasised that proxies may vote at their discretion on any resolution lacking specific shareholder instructions and on any other properly introduced business at the meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TenNor Therapeutics Releases Proxy Details for 29 June 2026 Annual Shareholders’ Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenNor Therapeutics Releases Proxy Details for 29 June 2026 Annual Shareholders’ Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-08 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.</p>\n<p>Shareholders will vote on six ordinary resolutions:</p>\n<p>1. 2025 board of directors’ work report  \n2. 2025 performance report of independent non-executive directors  \n3. 2025 annual financial report  \n4. 2025 profit distribution plan  \n5. Remuneration plan for the current board session’s directors  \n6. Appointment of the external auditor for the 2026 fiscal year</p>\n<p>H-shareholders wishing to appoint a proxy must submit the completed form—with any required notarised authorisations—to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, no later than 2:00 p.m. on 28 June 2026. Joint shareholders may vote through the first-named holder on the register, and any alterations to the proxy form must be initialled by the signatory.</p>\n<p>The company emphasised that proxies may vote at their discretion on any resolution lacking specific shareholder instructions and on any other properly introduced business at the meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06872","symbol_name":"丹诺医药-B","start_time":0,"source_url":"","article_id":"1149845710","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149845710","pubTimestamp":1780929799,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06872":"丹诺医药-B"},"translate_title":"TenNor Therapeutics发布2026年6月29日年度股东大会的代理详细信息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06872":1},"content_text":"TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.\nShareholders will vote on six ordinary resolutions:\n1. 2025 board of directors’ work report  \n2. 2025 performance report of independent non-executive directors  \n3. 2025 annual financial report  \n4. 2025 profit distribution plan  \n5. Remuneration plan for the current board session’s directors  \n6. Appointment of the external auditor for the 2026 fiscal year\nH-shareholders wishing to appoint a proxy must submit the completed form—with any required notarised authorisations—to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, no later than 2:00 p.m. on 28 June 2026. Joint shareholders may vote through the first-named holder on the register, and any alterations to the proxy form must be initialled by the signatory.\nThe company emphasised that proxies may vote at their discretion on any resolution lacking specific shareholder instructions and on any other properly introduced business at the meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149845710","isCrawlerRequest":true}